Fig 1. Flow chart of patients.

^aWe initially only planned to include microscopy confirmed patients, but due to the high proportion of patients treated empirically, we amended the inclusion criteria. One patient treated empirically was excluded because at the time of starting miltefosine, the amendment was not yet approved.